Transition Therapeutics (TTHI) is a product-focused biopharmaceutical company developing therapeutics for disease indications with large markets. This stock is trading up 6% at $2.25 in recent trading.
Today's Range: $2.12-$2.2552-Week Range: $1.15-$3.00 Volume: 5,916 Three-Month Average Volume: 19,118 >>22 Biopharma Stocks With Breakout Potential From a technical perspective, TTHI is jumping to the upside here with light volume. This move has pushed the stock into near-term breakout territory, since TTHI has taken out some resistance at $2.16. Traders should now look to play the next major breakout trade for TTHI. That trade will trigger once TTHI takes out some near-term overhead resistance at $2.35 with high-volume. Traders should look for long-biased trades once TTHI sustains a move or close over $2.35 with volume that's near or above 19,118 shares. If that breakout triggers soon, then TTHI has an excellent chance of tagging its next major overhead resistance levels at $2.79 to $3.23 in the near future.